Mizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks

February 4, 2025
Mizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocksMizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks
Share This

Jared Holz, Mizuho Securities America healthcare sector strategist, joins ‘Squawk Box’ to break down the quarterly earnings results of Merck and Pfizer, 2025 outlook for pharmaceutical stocks, and more.

Latest Mizuho News

Mizuho Financial Group launches strategic technology and operations center in Pune

Mizuho Financial Group launches strategic technology and operations center in Pune

May 21, 2026
A lot of concern around consumer spending ahead of retail earnings, says Mizuho’s Bellinger

A lot of concern around consumer spending ahead of retail earnings, says Mizuho’s Bellinger

May 19, 2026
Why biotechnology stocks have more room to run

Why biotechnology stocks have more room to run

May 12, 2026

Mizuho news from around the globe

back-to-top-blue